AU2002952355A0 - Cephem compounds - Google Patents

Cephem compounds

Info

Publication number
AU2002952355A0
AU2002952355A0 AU2002952355A AU2002952355A AU2002952355A0 AU 2002952355 A0 AU2002952355 A0 AU 2002952355A0 AU 2002952355 A AU2002952355 A AU 2002952355A AU 2002952355 A AU2002952355 A AU 2002952355A AU 2002952355 A0 AU2002952355 A0 AU 2002952355A0
Authority
AU
Australia
Prior art keywords
cephem compounds
cephem
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002952355A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd, Fujisawa Pharmaceutical Co Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Priority to AU2002952355A priority Critical patent/AU2002952355A0/en
Publication of AU2002952355A0 publication Critical patent/AU2002952355A0/en
Priority to AT03758919T priority patent/ATE368042T1/en
Priority to PCT/JP2003/013684 priority patent/WO2004039814A1/en
Priority to AU2003274754A priority patent/AU2003274754A1/en
Priority to CA2504730A priority patent/CA2504730C/en
Priority to BRPI0315188A priority patent/BRPI0315188B8/en
Priority to KR1020057007538A priority patent/KR101023035B1/en
Priority to DK03758919.9T priority patent/DK1556389T6/en
Priority to CNB2003801026422A priority patent/CN100343260C/en
Priority to JP2005501847A priority patent/JP4448821B2/en
Priority to DE60315178.7T priority patent/DE60315178T3/en
Priority to EP03758919.9A priority patent/EP1556389B9/en
Priority to PT03758919T priority patent/PT1556389E/en
Priority to ES03758919.9T priority patent/ES2290498T7/en
Priority to TW092129984A priority patent/TWI319403B/en
Priority to ARP030103985A priority patent/AR041729A1/en
Priority to US10/695,895 priority patent/US7129232B2/en
Priority to ZA200504181A priority patent/ZA200504181B/en
Priority to HK06106532A priority patent/HK1086566A1/en
Priority to US11/585,262 priority patent/US20070037786A1/en
Priority to LU92943C priority patent/LU92943I2/en
Priority to BE2016C002C priority patent/BE2016C002I2/fr
Priority to HUS1600008C priority patent/HUS1600008I1/en
Priority to FR16C0004C priority patent/FR16C0004I2/en
Priority to NL300793C priority patent/NL300793I1/nl
Abandoned legal-status Critical Current

Links

AU2002952355A 2002-10-30 2002-10-30 Cephem compounds Abandoned AU2002952355A0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
AU2002952355A AU2002952355A0 (en) 2002-10-30 2002-10-30 Cephem compounds
CNB2003801026422A CN100343260C (en) 2002-10-30 2003-10-27 Cephem compounds
PT03758919T PT1556389E (en) 2002-10-30 2003-10-27 Cephem compounds
ES03758919.9T ES2290498T7 (en) 2002-10-30 2003-10-27 Cefem compounds
AU2003274754A AU2003274754A1 (en) 2002-10-30 2003-10-27 Cephem compounds
CA2504730A CA2504730C (en) 2002-10-30 2003-10-27 Cephem compounds
BRPI0315188A BRPI0315188B8 (en) 2002-10-30 2003-10-27 compound and pharmaceutical composition
KR1020057007538A KR101023035B1 (en) 2002-10-30 2003-10-27 Cephem compounds
DK03758919.9T DK1556389T6 (en) 2002-10-30 2003-10-27 cephem
PCT/JP2003/013684 WO2004039814A1 (en) 2002-10-30 2003-10-27 Cephem compounds
JP2005501847A JP4448821B2 (en) 2002-10-30 2003-10-27 Cephem compound
DE60315178.7T DE60315178T3 (en) 2002-10-30 2003-10-27 cephem
EP03758919.9A EP1556389B9 (en) 2002-10-30 2003-10-27 Cephem compounds
AT03758919T ATE368042T1 (en) 2002-10-30 2003-10-27 CEPHEMEM COMPOUNDS
TW092129984A TWI319403B (en) 2002-10-30 2003-10-29 Cephem compounds
ARP030103985A AR041729A1 (en) 2002-10-30 2003-10-30 CEFEMO COMPOUND
US10/695,895 US7129232B2 (en) 2002-10-30 2003-10-30 Cephem compounds
ZA200504181A ZA200504181B (en) 2002-10-30 2005-05-23 Cephem compounds
HK06106532A HK1086566A1 (en) 2002-10-30 2006-06-07 Cephem compounds
US11/585,262 US20070037786A1 (en) 2002-10-30 2006-10-24 Cephem compounds
LU92943C LU92943I2 (en) 2002-10-30 2016-01-12 CEFTOLOZANE OR A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR A SALT OF SULFURIC ACID (ZERBAXA)
BE2016C002C BE2016C002I2 (en) 2002-10-30 2016-01-21
HUS1600008C HUS1600008I1 (en) 2002-10-30 2016-01-28 Cephem compounds
FR16C0004C FR16C0004I2 (en) 2002-10-30 2016-02-03 CEPHEM COMPOUNDS
NL300793C NL300793I1 (en) 2002-10-30 2016-02-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2002952355A AU2002952355A0 (en) 2002-10-30 2002-10-30 Cephem compounds

Publications (1)

Publication Number Publication Date
AU2002952355A0 true AU2002952355A0 (en) 2002-11-14

Family

ID=28795748

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002952355A Abandoned AU2002952355A0 (en) 2002-10-30 2002-10-30 Cephem compounds

Country Status (3)

Country Link
CN (1) CN100343260C (en)
AU (1) AU2002952355A0 (en)
ZA (1) ZA200504181B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US10420841B2 (en) 2013-03-15 2019-09-24 Merck, Sharp & Dohme Corp. Ceftolozane antibiotic compositions

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103945842A (en) * 2011-09-09 2014-07-23 丘比斯特药物股份有限公司 Methods for treating intrapulmonary infections
EP2628730B1 (en) * 2012-02-16 2017-12-06 Noxell Corporation Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1h-pyrazole salts
KR102329764B1 (en) * 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 Ceftolozane antibiotic compositions
EP3180347B1 (en) * 2014-08-15 2020-09-23 Merck Sharp & Dohme Corp. Synthesis of cephalosporin compounds
US10532058B2 (en) * 2015-09-08 2020-01-14 Sandoz Ag Process for preparing ceftolozane from 7-aminocephalosporanic acid (7-ACA)
CN107556328B (en) * 2016-07-01 2020-10-09 正大天晴药业集团股份有限公司 Intermediate for preparing cephem compound and crystal thereof
CN107586305A (en) * 2017-06-23 2018-01-16 浙江惠迪森药业有限公司 A kind of beta-lactam class compound carboxyl and hydroxyl protecting group removal methods
CN111732543A (en) * 2020-08-14 2020-10-02 浙江鼎龙科技有限公司 Preparation method of 4, 5-diamino-1- (2-hydroxyethyl) pyrazole sulfate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78245B (en) * 1980-09-12 1984-09-26 Ciba Geigy Ag
GB9023479D0 (en) * 1990-10-29 1990-12-12 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US10420841B2 (en) 2013-03-15 2019-09-24 Merck, Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US11278622B2 (en) 2013-03-15 2022-03-22 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US10933053B2 (en) 2013-09-09 2021-03-02 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function

Also Published As

Publication number Publication date
ZA200504181B (en) 2006-08-30
CN1708502A (en) 2005-12-14
CN100343260C (en) 2007-10-17

Similar Documents

Publication Publication Date Title
HUS1600008I1 (en) Cephem compounds
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003221080A1 (en) Broad-spectrum cephem compounds
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2003279366A1 (en) Novel compounds
WO2003072535A8 (en) Substituted hydroxyethylamines
AU2002950161A0 (en) Dvd improvements
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003252028A1 (en) Heterodiamondoids
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003902380A0 (en) Cephem compounds
AU2002952355A0 (en) Cephem compounds
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AUPS044102A0 (en) New compound
AU2002951868A0 (en) Compound i
AU2003292667A1 (en) Benzocycloheptapyridine compounds
AU2003251259A1 (en) Novel compounds
AU2002318053A1 (en) Suplier
AU2003255322A1 (en) Compounds
AU2003275480A1 (en) Compounds
AU2003274754A1 (en) Cephem compounds
AU2003905084A0 (en) Cephem Compounds